DeFaller, J.M., Database Dissertation Abstracts University Microfilms International, “Mechanisms of Action and Clinical Efficacy of AL-3789, an Angiostatic Steroid (Neovascularization, Pterigium, Tumor Growth),” vol. 58/06B:2974. |
Miller, et al., Arch Ophthalmol. “Photodynamic Therapy of Experimental Choroidal Neovascularization Using Lipoprotein-Delivered Benzoporphyrin,” vol. 113:810-818, 1995. |
Cowled, et al., Cancer Letters, “Potentiation of Photodynamic Therapy with Haematoprphyrin Derivatives by Glucocorticoids,” vol. 29:107-114, 1985. |
Anderson, et al., Photochemistry and Photobiology, “Phthalocyanine Photodynamic Therapy: Disparate Effects of Pharmacolognic Inhibitors on Cutaneous Photosensitivity and on Tumor Regression,” vol. 65(5):895-901; 1997. |
Clark, Abbot F., Exp. Opin. Invest. Drugs, “Cardiovascular & Renal AL-3789: a novel ophthalmic angiostatic steroid,” vol. 6(12):1867-1877, 1997. |
Nirankari, Verinder S., Tr. AM. Ophtal. Soc., “Laser Photocoagulation for Corneal Stromal Vascularization,” vol. LXXXX, pp. 595-669, 1992. |
Crum, et al., A New Class of Steroids Inhibits Angiogenesis In the Presence of Heparin or Heparin Fragment, Science, vol. 230:1375-1378, Dec. 20, 1985. |
Ingber, et al., A Possible Mechanism for Inhibition of Angiogenesis by Angiostatic Steroids: Induction of Capillary Basement Membrane Dissolution, Endocrinology, vol. 119(4):1768-1775, 1986. |
Li, et al., Angiostatic Steroids Potentiated by Sulphated Cyclodextrin Inhibit Corneal Neovascularization, Investigative Ophthalmology and Visual Science, vol. 32(11):2898-2905, Oct., 1991. |
Asrani & Zeimer, Feasibility of Laser Targeted Photo-Occlusion of Ocular Vessels, Br J Ophthalmol., vol. 79(8):776-770, Aug., 1995. |
Asrani et al, Feasibility of Laser Targeted Photoocclusion of the Choriocapillary Layer in Rats, Investigative Ophthalmol. & Vis. Sci., vol. 38(13):2702-2710, Dec., 1997. |
Husain et al, Photodynamic Therapy and Digital Angiography of Experimental Iris Neovascularization Using Liposomal Benzoporphyrin Derivative; Ophthalmology, vol. 104(8):1242-1250, Aug., 1997. |
Lin et al, The Photodynamic Occlusion of Choroidal Vessels Using Benzoporphyrin Derivative, Curr Eye Res, vol. 13(7):513-522, Jul., 1994. |
Gragoudas et al, Results and Preliminary Dosimetry of Photodynamic Therapy for Choroidal Neovascularization . . . , Investigative Ophthalmology & Visual Science, vol. 38(4):S17, Mar. 15, 1997. |
Sickenberg et al, Preliminary Results of Photodynamic Therapy for Choroidal Neovascularization in . . . , Investigative Ophthalmology & Visual Science, vol. 38(4):S92, Mar. 15, 1997. |
Thomas et al, Purlytin™ (SnET2)-Photodynamic Therapy Produces Closure or Subfoveal Choroidal . . . , Investigative Ophthalmology & Visual Science, vol. 39(4):S242, Mar. 15, 1998. |
Folkman, et al., Angiogenic Factors, Science, vol. 235, pp. 442-447, 1987. |
Furcht, Critical Factors Controlling Angiogenesis: Cell Products, Cell Matrix, and Growth Factors, Laboratory Investigation, vol. 55(5):505-509, 1986. |
Cariou, et al., Inhibition of Human Endothelial Cell Proliferation by Heparin and Steroids, Cell Biology International Reports, vol. 12(12):1037-1047, Dec., 1988. |
Tokida, et al., Production of Two Variant Laminin Forms by Endothelial Cells and Shift of Their Relative Levels by Angiostatic Steroids, The Journal of Biological Chemistry, vol. 265(30):18123-18129, Oct. 25, 1990. |
Maragoudakis, et al., Antiangiogenic Action of Heparin Plus Cortisone is Associated with Decreased Collagenous Protein Synthesis in the Chick Chorioallantoic Membrane System, The Journal of Pharmacology and Experimental Therapeutics, vol. 251(2):679-682, 1989. |
Ashino-Fuse, et al., Medroxyprogesterone Acetate, An Anti-Cancer and Anti-Angiogenic Steroid, Inhibits the Plasminogen Activator in Bovine Endothelial Cells, Int. J. Cancer, vol. 44:859-864, 1989. |
BenEzra, Neovasculogenic Ability of Prostaglandins, Growth Factors, and Synthetic Chemoattractants, American Journal of Ophthalmology, vol. 86(4):455-461, Oct., 1978. |